Previous studies have shown that the singlestranded DNA binding protein of bacteriophage fi (gene V protein) represses the translation of the mRNA of the phageencoded replication protein (gene HI protein). We have characterized phage mutations in the repressor and in its target. Using a gene II-lacZ translational fusion, we have defined a 16-nucleotide-long region in the gene HI mRNA sequence that is required in vivo for repression by the gene V protein. We have shown that in vitro the binding affinity of the gene V protein is at least 10-fold higher to an RNA carrying this sequence than to an RNA lacking it. We propose that this sequence constitutes the gene HI mRNA operator.
Two phage-encoded gene products are required for the replication of filamentous phage DNA. One, the gene II protein (gpII), is a site-specific endonuclease that initiates rolling-circle replication by introducing a nick at the replication origin (1) and that also participates in termination of replication (2) . The other, gene V protein (gpV), is a small dimeric protein that binds to single-stranded DNA and prevents its doubling up, thereby allowing the DNA to be packaged into virions (3) . In addition to its role in DNA binding, gpV specifically represses the translation ofthe gene II mRNA (4, 5) .
The DNA of the phage replication origin contains two domains (6): a core sequence 40 base pairs (bp) long containing the nicking site with the related gpII binding sites (7) and, downstream from it, a 100-bp-long replication enhancer region, which contains binding sites for the Escherichia coli integration host factor (IHF; ref. 8) . Small insertions in the enhancer region decrease phage growth by a factor of 100, but compensatory mutations can be selected that are of two kinds: base substitutions in the coding sequence of gene II that render the protein IHF independent (8, 9) , and mutations leading to gene II overproduction (9, 10) . Two mutations belonging to this latter class have been characterized already, one in the gene II mRNA leader sequence and one in the gene V coding sequence (10) .
gpV has been shown to repress the synthesis of gpII at the level of translation both in vitro and in vivo (4, 5) . The existence of gpV mutants that overproduce gpII genetically confirms its role as the gene II repressor. In addition, the localization in the gene II mRNA leader sequence of a mutation that also abolishes repression supports a role for this sequence as the RNA operator. In this paper we describe the characterization of the minimal sequence of gene II mRNA required for translational repression. A (9)], and R408 (15) . fl nucleotides are numbered according to Hill and Petersen (16) . For construction of the phage R485, the replicative forms (RF) of R143 and R218 were cleaved with Sau96I and Cla I, and the resulting fragments were mixed and ligated. The ligation mixture was introduced into strain K37, and turbid plaques were screened on a nonsuppressing strain. A phage, R485, which was amber, gave turbid plaques, and carried an EcoRI site, was used to screen for clear revertants.
Plasmids and Plasmid Constructions. Construction of pIIlac-I and pIIlac-2 is described in the legend to Fig. 1 . Plasmids used for these constructions are pACYC184 (17, 18) , pSKS107 (13), pSS9 (19) , and the RF form ofphage R299. All cohesive ends were rendered blunt with Klenow polymerase; linearized vectors were dephosphorylated and gelpurified by electroelution prior to ligation. The plasmid pLV has been described (20) . Plasmids pTZ18R and pTZ19R (Pharmacia) were used as vectors for cloning the oligonucleotides for in vitro RNA synthesis. These plasmids were cleaved with EcoRI and HindIII and were gel-purified, and the oligonucleotides 16, 19, or 33 (nucleotides 5965-5985, 5965-5988, or 5965-6002 of fl, respectively, flanked by EcoRI and HindIII protruding ends) were cloned into each vector. pTZ18R was used for the construction of pTZII-16, pTZII-19, and pTZII-33, and pTZ19R was used for pTZII-19C and pTZII-33C.
Plasmid DNA was prepared by the alkaline lysis technique (21) or a clear lysate method (22) . DNA was sequenced by the dideoxy sequencing technique (23) . S1 nuclease digestion was performed as described (24) with 1 gg of BstEIIlinearized DNA and 0.5 unit of S1 nuclease for 20 min at room temperature. The DNA was digested again by BstEII prior to transformation.
Marker Rescue Mapping. Phage stocks made from independent clear plaque revertants of R485 were used to prepare single-stranded DNA. These DNAs were hybridized to double-stranded fragments as described (25) . One (27) containing chloramphenicol (25 bromo-4-chloro-3-indolyl ,-D-galactoside (X-Ga and the f3-galactosidase inhibitor phenylethyl thi (0.5 mM) (28) . Wild-type transformants product onies on this medium, while mutant colonies X dark blue. One blue colony per pool was further oligonucleotides used were: 5'-GGTTGATA) AAGCCCCAAA-3' and 5'-GATAATCAGAA AAAAACA-3', where H is an equal mixture of and 5'-AATCAGllllG222211111CAGGA-3', w Aand4%eachG,T, andC,and2is88%Cand G, and T. For the construction of pIIlac-3, the tide used was: 5'-CCCCGGTTGGTAACCAG. CC-3'. f-Galactosidase assays were performed by Miller (27) . The p-galactosidase activity was strain K1043 with and without pLV and in s (pLV) in the presence and absence of isopropyl oh pACYC184
side. Similar levels of expression and repression were observed in both systems.
RNA Synthesis and Purification. For RNA synthesis the plasmids were cleaved with Ssp I restriction enzyme, and the larger fragment was gel-purified by electroelution. Reactions were as described by Uhlenbeck and coworkers (29) with 1 pug of linear purified template and 60 units of T7 RNA polymerase for 2 hr at 370C. RNA was purified by electrophoresis on a 4% acrylamide/6 M urea gel as described (30) .
Conditions for gel-shift experiments are described in the legend to Fig. 4 .
gpV Purification. gpV was purified as described (31) 130-bp-long sequence including the gene II promoter and the gene II nucleotides encoding the 12 first amino acids of gpII was fused to a lacZ gene deleted for its own transcriptional and translational initiation signals.
First, a truncated lacZ gene missing its first six codons was cloned from the plasmid pSKS107 to the plasmid pACYC184. Next, the terminator of transcription of the phage A oop RNA from plasmid pSS9 was cloned downstream of this truncated lacZ gene. Finally the EcoRI-Cla I fragment of the phage R299, which carries the gene II promoter and translational initiation signal, was cloned in front of the truncated lacZ gene. In this final construct (plasmid pIIlac-1, see Fig. 1 ), a fusion protein carrying the first 12 amino acids encoded by gene 11 fused to 9 amino acids encoded by the pSKS107 polylinker and in turn fused to amino acid 7 encoded by lacZ is expressed under the control of the gene II promoter.
To measure the level of repression by gpV, we used a plasmid in which gene V had been placed under the control of the inducible promoter lacUVS. In this plasmid, named pLV (20) , gpV is fully repressed in a lac IP strain, but it is induced upon addition of isopropyl thiogalactoside. pLV carries an ampicillin-resistance marker and replicates by using a pBR322 origin; thus, pLV and pIIlac-1 are compatible. They were introduced into the lac Pq strain JM101, and the level of p-galactosidase activity was measured in the presence and absence of the gene V inducer isopropyl thiogalactoside. When gpV was induced, P-galactosidase activity decreased from 600 ± 100 to 60 ± 10 units. Thus, gpV represses the expression of a lacZ gene under the control of gene II transcriptional and translational signals by at least a factor of 10. Mutations in the First 16 Nucleotides of Gene II mRNA Affect Repression. To study their role in detail, the first 16 nucleotides of the gene H mRNA were modified by sitedirected mutagenesis. To prepare single-stranded DNA containing these nucleotides, a 448-bp-long fragment of phage fi carrying the replication origin and the morphogenetic signal required for encapsidation was cloned into pIIlac-1, giving pIIlac-2 (Fig. 1) . Site-directed mutagenesis was performed, and mutants were obtained by screening for a Lac' phenotype (blue on indicator plates) in the presence of gpV. The mutagenic oligonucleotides were designed to produce all possible changes at any position from nucleotides 2 to 16 of the gene II leader: a degenerate oligonucleotide was used for the mutagenesis of uridine and guanosine residues; and two other oligonucleotides, for the two cytidine residues. The 14 mutants obtained are shown in Fig. 2 . B-Galactosidase activity was the same as in wild-type pIIlac-2 for each mutant in the absence of repression, showing that translation was unchanged. Two types of mutants were found. For some the level of repression by gpV was no more than a factor of 1.4 compared to 10 with the wild-type operator. These colonies were dark blue on indicator plates ( Fig. 2 ; mutations in underlined bold letters). For the others the level ofrepression was about a factor of 2, and they produced light-blue colonies on indicator plates ( Fig. 2 ; mutations in italics).
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Fourteen independent dark-blue clones obtained with the degenerate oligonucleotide were analyzed to give the 6 different mutants shown here ( Fig. 2 ; those with underlined bold letters). There is statistically an 11% chance that a seventh one could have been missed but only a 1.8% chance that 2 others could exist and not be found among the 14 analyzed. Thus, a minority of the mutations (6 or 7 among 39 possible ones that can be made with the degenerate oligonucleotide) lead to nearly completely impaired repression. By contrast, the same mutation was rarely obtained twice among the light-blue colonies; thus, others of this second type may exist and would be found in a larger sample. Silent mutations or those repressed by a factor > 2 could not be found with the screening procedure used.
Mutations Outside This Region Do Not Affect Repression. A double mutant that combines A19G and T23C (downstream from nucleotide 16), which creates a Bst EII restriction site, was constructed by site-directed mutagenesis. The resulting plasmid, pIIlac-3 (Fig. 3) , was introduced into strain JM101 (pLV), and the B-galactosidase activity was measured in the presence and absence of gpV. The lacZ gene was repressed in the presence of gpV at the same level as in the plasmids pIIlac-1 and pIIlac-2, which carry the wild-type gene II mRNA sequence. Thus, even a double mutation in this downstream region does not affect translation or translational repression by gpV.
The downstream region was further modified by BstEII restriction and treatment with S1 nuclease. Four different plasmids were obtained. In one, the five nucleotides corresponding to the BstEII protruding ends were removed (Fig.  3 , plasmid Al). Two additional nucleotides were deleted in the three other plasmids (Fig. 3, plasmids A2-A4) . Thus, new sequences were brought adjacent to nucleotide 16 of gene II mRNA: thymidine-17 was replaced by a cytidine in A4; and guanosine-18, by an adenosine in A3 (Fig. 3) . In the absence of gpV, the level of ,B-galactosidase activity was the same as in pIIlac-2 and pIIlac-3; therefore, these modifications did not affect the efficiency of translation. P-Galactosidase activity was also identical to that of the control plasmids in the presence of gpV: the level of repression was not significantly affected.
The results described in this section indicate that, in contrast to nucleotides [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] of gene II mRNA, the next 9 nucleotides (thymidine-17 to adenosine-26) can be modified without affecting translational repression. However, this sequence might play a role as a spacer separating the operator sequence from the ribosome binding site (RBS). When a 5-bp insertion was created in this region by filling in the BstEII protruding ends with Klenow polymerase (plasmid K in Fig.  3 ), the level of repression was only a factor of 2 compared with 10 for its parent. It may be that simply increasing the distance between the operator and the RBS can decrease the efficiency of translational repression. However, to assure this point, further work is needed. acrylamide/Tris-EDTA-borate gel (24) . Electrophoresis was performed at 200 V for 2 hr, and the gel was dried and exposed for 2-12 hr. Lanes: 1-6, 0, 0.26, 0.78, 2.6, 7.8, and 26 ,M gpV.
10-fold higher affinity than to RNAs of the same size lacking this sequence.
To determine if the presence of more of the gene II mRNA sequence would further increase gpV affinity, a plasmid was constructed with the first 33 nucleotides of gene II mRNA (pTZII-33). Results obtained with RNAs from pTZII-33, pTZII-19, and pTZII-16 were identical. The control RNA, where complementary nucleotides were present (pTZII-33C), behaved as the previous controls. Therefore, no more information for binding was provided by the addition of the 17 nucleotides on the 3' end of the operator. The first 16 nucleotides of gene II mRNA seem to contain all of the information required for preferential gpV binding in vitro.
DISCUSSION
gpV represses the translation of gene II mRNA in vivo and in vitro (4, 5) . We have now shown that nucleotides 1-16 of gene II leader mRNA constitute the target for repression, as was suspected by Fulford and Model (32) . We have constructed a system that allows us to measure the level of repression by using a P3-galactosidase assay. We have shown by site- directed mutagenesis that at least 9 of the first 16 nucleotides of gene II mRNA cannot be changed without decreasing repression. In contrast, mutations at both nucleotides 19 and 23 or small deletions starting at nucleotide 17 or 18 of gene HI mRNA do not affect translational repression. In addition, when these 16 nucleotides are present on an RNA synthesized in vitro, gpV binds to this RNA with a 10-fold higher affinity, confirming the genetic localization of the operator.
Mutations also have been obtained in gene V and gene II mRNA leader sequence by screening for clear plaque revertants of replication-defective phages. Two of the previously described mutations obtained by this screen (R218 and R325; ref. 9) have been shown to result in overproduction of gpII.
In addition, two of the mutations isolated here, Arg-80-* Cys and Arg-82-* Cys, which were also obtained by other means, were shown to cause overproduction of gpII (K. Horiuchi, personal communication). Therefore, we assume that all of the gene II mRNA leader sequence and the gene V mutants obtained by this screen are gpII overproducers. This was confirmed for the R491 mutation, which prevents repression, when assayed with the gene II-lacZ fusion (mutation G1OA in Fig. 2) . The Arg-80 -* Cys mutant gpV was purified and shown to bind in vitro to both single-stranded DNA and RNA with a reduced affinity. In spite of this impaired nucleic acid binding, it still retained a higher affinity for the operator RNA sequence compared with other RNAs (data not shown). This could account for the ability of the mutant protein to allow phage production but repress gene II only partially. The binding properties of the other mutant proteins remain to be determined.
Assuming that the level of repression with the various combinations of gene II mutants and gpV in this plasmid Biochemistry: Michel and Zinder 0 VW system reflects events in fi phage infections, we note the following. The mutations in nucleotides 1-16 of gene II mRNA are of two types: some in which <25% of repression remains (T14, T15, and G10) and others in which lacZ is repressed about 50%, suggesting that some gpV binding can still occur. Phage mutations obtained in the gene II mRNA leader sequence belong to these two classes, showing that 50% repression allows the synthesis of enough gpV to compensate for the defective replication origin (R325 = G9T) and that full derepression is not lethal for the phage (R491 = G1OA), at least in the presence of a defective origin.
gpV binds with high affinity and high cooperativity to single-stranded DNA (33, 34) . It has reduced affinity for RNA, and binding is much less cooperative (35, 36) . Binding to RNA that lacks the gene II operator, visualized here by a gel retardation assay, is not cooperative; a smear is found at intermediate gpV concentrations (Fig. 4B) (Fig. 4A) Translational repression is a common way of gene regulation for several phages (T4, Qf8, and R17). Ribosomes are known to protect 10-12 nucleotides upstream from the Shine-Dalgarno sequence (38) , the nature of this sequence being important in ribosomal recognition (39) . For most ofthe phage genes repressed at the level of translation, at least part of the RBS is covered by the repressor (40) . However, for the ribosomal S4 protein mRNA, the repressor binds at a distance from the RBS but disrupts a special structure required for translation initiation (41) . The 3' end of the gene II operator is located 12 (43) .
No secondary structure is apparent for the operator described here. It has been proposed that it is the very absence of structure that is necessary for gpV recognition (44) , but from the work presented here, it is apparent that specific nucleotides at several positions are also required. These subtle interactions of sequence and structure remain to be sorted out.
